Skip to main content

Insiders Seeing Green With CNCE At New 52-Week High

In trading on Monday, shares of Concert Pharmaceuticals Inc (CNCE) touched a new 52-week high of $7.17/share. That's a 178.99% rise, or $4.6 per share from the 52-week low of $2.57 set back on 02/24/2022..
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.